Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

F3 Issues Common Shares for Interest Debt Settlement Ready to Announce with Confidence?

newsfilecorp.com
DNN

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages FS KKR Capital Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FSK

accessnewswire.com
FSK

NEW ERA DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages New Era Energy & Digital, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 1 Deadline in Securities Class Action - NUAI

accessnewswire.com
NUAI

ROSEN, SKILLED INVESTOR COUNSEL, Encourages SES AI Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - SES

accessnewswire.com
SES

El socio de Avanzanite Bioscience, Agios anuncia la autorización de PYRUKYND® (mitapivat) en la Unión Europea para adultos con talasemia

businesswire.com
AGIO

Rosen Law Firm Encourages UP Fintech Holding Limited Investors to Inquire About Securities Class Action Investigation – TIGR

businesswire.com
TIGR

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zillow Group, Inc. Investors to Inquire About Securities Class Action Investigation - Z, ZG

accessnewswire.com
Z RDN

Avanzanite Bioscience’s partner Agios maakt de goedkeuring van PYRUKYND® (mitapivat) in de Europese Unie bekend voor volwassenen met thalassemie

businesswire.com
AGIO

Agios, partner di Avanzanite Bioscience, annuncia l'approvazione di PYRUKYND® (mitapivat) nell'Unione europea per gli adulti affetti da talassemia

businesswire.com
AGIO

ALDX FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 29 Deadline in Securities Class Action First Filed by the Firm - ALDX

accessnewswire.com
ALDX
View all news →